查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298255

鼻噴霧劑市場：按類型、應用、分銷渠道：2021-2031 年全球機會分析和行業預測

Nasal Spray Market By Type, By Application, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 397 Pages | 商品交期: 2-3個工作天內

價格

2021年鼻噴霧劑市場價值為92.1212億美元，預計到2031年將達到168.5569億美元，2022年至2031年的複合年增長率為6.2%。

鼻噴霧劑可用於治療鼻過敏和鼻充血，並可有效輸送過敏藥物。 鼻過敏可引起發燒、咳嗽、口臭和鼻後滴漏等疾病。 鼻噴霧劑具有多種優點，包括有效且無痛的藥物輸送、增加患者便利性以及廣泛的可用性。 鼻噴霧劑還可作為藥丸的替代品，允許無針給藥。 最佳給藥途徑被認為是經鼻給藥。 畢竟，通過鼻子快速直接給藥對患者的呼吸系統有重大影響。

鼻噴霧劑市場-IMG1

由於患有各種呼吸道疾病的老年人口不斷增加、創新技術的推出、醫療保健支出的增加以及政府支持的增加，預計鼻噴霧劑市場在預測期內將出現顯著的市場增長。估計和預測預期的。 此外，公司正在增加研發投資、強大的候選產品的存在以及增加醫療基礎設施的支出，這將進一步推動新興市場的增長。 然而，嚴格而漫長的產品審批流程預計將阻礙市場增長。 另一方面，私營和公共部門醫療保健投資的激增預計將為鼻噴霧劑市場提供重大增長機會。

鼻噴霧劑市場按類型、應用、分銷渠道和地區進行細分。 按類型劃分，市場分為類固醇、抗組胺藥、鹽水、減充血劑等。 按應用，市場分為過敏性鼻炎、鼻竇炎、鼻息肉等。 按分銷渠道劃分，市場分為醫院藥房、藥店和零售藥房以及在線提供商。

內容

第1章簡介

第 2 章執行摘要

第3章市場概述

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭強度
  • 市場動態
    • 協調員
      • 鼻部疾病患病率增加
      • 仿製藥鼻噴霧劑的開發和上市數量增加
      • 鼻噴霧劑需求增加
    • 阻礙因素
      • 與鼻噴霧劑相關的副作用
    • 機會
      • 新興經濟體的增長潛力
  • COVID-19 對市場的影響分析

第 4 章鼻噴霧劑市場，按類型

  • 概述
    • 市場規模和預測
  • 類固醇
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 抗組胺藥
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 生理鹽水
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 減充血劑
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分

第5章鼻噴霧劑市場：按應用

  • 概述
    • 市場規模和預測
  • 過敏性鼻炎
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 鼻竇炎
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 鼻息肉
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分

第 6 章鼻噴霧劑市場：按分銷渠道劃分

  • 概述
    • 市場規模和預測
  • 醫院藥房
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 藥店和零售藥店
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分
  • 在線提供商
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區劃分
    • 市場份額分析：按國家/地區劃分

第7章鼻噴霧劑市場：按地區

  • 概述
    • 市場規模/預測：按地區劃分
  • 北美
    • 主要趨勢和機遇
    • 市場規模/預測：按類型
    • 市場規模和預測：按應用分類
    • 市場規模和預測：按分銷渠道劃分
    • 市場規模/預測：按國家/地區劃分
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
  • 歐洲
    • 主要趨勢和機遇
    • 市場規模/預測：按類型
    • 市場規模和預測：按應用分類
    • 市場規模和預測：按分銷渠道劃分
    • 市場規模/預測：按國家/地區劃分
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 歐洲其他地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
  • 亞太地區
    • 主要趨勢和機遇
    • 市場規模/預測：按類型
    • 市場規模和預測：按應用分類
    • 市場規模和預測：按分銷渠道劃分
    • 市場規模/預測：按國家/地區劃分
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 亞太地區其他地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
  • 拉丁美洲/中東/非洲
    • 主要趨勢和機遇
    • 市場規模/預測：按類型
    • 市場規模和預測：按應用分類
    • 市場規模和預測：按分銷渠道劃分
    • 市場規模/預測：按國家/地區劃分
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分
      • 其他地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按應用分類
      • 市場規模和預測：按分銷渠道劃分

第 8 章競爭格局

  • 簡介
  • 關鍵成功策略
  • 10家主要公司的產品圖譜
  • 競賽儀表板
  • 比賽熱圖
  • 頂級公司定位(2021 年)

第 9 章公司簡介

  • GlaxoSmithKline plc
  • Novartis AG
  • Cipla Ltd
  • Bayer AG
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd
  • Aurena Laboratories
  • Apotex Inc.
  • Leeford Healthcare Limited
  • Sunovion Pharmaceuticals Inc.
Product Code: A14430

The nasal spray market valued for $9,212.12 million in 2021 and is estimated to reach $16,855.69 million by 2031, exhibiting a CAGR of 6.2% from 2022 to 2031.

Nasal sprays are useful for treating nasal allergies, clogged noses, and for effectively delivering allergy medications. Nasal allergies can lead to illnesses including fever, coughing, bad breath, and postnasal drips. Nasal sprays provide various benefits, including effective and painless drug administration, improved patient convenience, and widespread availability. Nasal sprays also function as an alternative to pills and allow for needle-free drug administration. The optimal route is thought to be nasal. After all, the fast and direct administration of the drug through the nose has a significant impact on the patient's respiratory system.

Nasal Spray Market - IMG1

It is estimated that nasal spray market is expected to experience significant market growth during the forecast period owing to the increasing geriatric population suffering from various respiratory disorder, the launch of innovative technologies, a boost in healthcare expenditure, and higher government support. In addition, increase in investment by players in R&D and presence of robust pipeline candidates and rise in expenditure on the development of healthcare infrastructure which further facilitate the growth of the market. However, strict, and extended product approval processes are expected to impede the market growth. In contrast, surge in healthcare investments in public as well as private sectors are anticipated to provide significant growth opportunities for the nasal spray market.

The nasal spray market is segmented based on type, application, distribution channel, and region. Depending on type, the market is classified into steroids, antihistamine, saline solutions, decongestants, and others. Based on application, the market is categorized into allergy rhinitis, sinusitis, nasal polyps, and others. Depending on distribution channel, the market is segregated into hospital pharmacies, drug stores & retail pharmacies, and online providers.

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The report provides a comprehensive analysis of the key players that operate in the global nasal spray market. The key companies profiled in the report include Apotex Inc., Aurena Laboratories, Bayer AG, Cipla Ltd, GlaxoSmithKline plc, Leeford Healthcare Limited, Novartis AG, Sunovion Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd, and Viatris Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nasal spray market analysis from 2021 to 2031 to identify the prevailing nasal spray market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nasal spray market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nasal spray market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Others
  • Steroid
  • Antihistamine
  • Saline Solution
  • Decongestant

By Application

  • Allergy Rhinitis
  • Sinusitis
  • Nasal Polyps
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

  • GlaxoSmithKline plc
  • Sun Pharmaceutical Industries Ltd
  • Aurena Laboratories
  • Bayer AG
  • Sunovion Pharmaceuticals Inc.
  • Leeford Healthcare Limited
  • Viatris Inc.
  • Cipla Ltd
  • Novartis AG
  • Apotex Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of nasal disorders
      • 3.4.1.2. Increasing number of generic nasal spray product development and launches
      • 3.4.1.3. Rise in demand for nasal sprays
    • 3.4.2. Restraints
      • 3.4.2.1. Side effects associated with nasal spray
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth potential of emerging economies
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: NASAL SPRAY MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Steroid
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Antihistamine
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Saline Solution
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Decongestant
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country
  • 4.6. Others
    • 4.6.1. Key market trends, growth factors and opportunities
    • 4.6.2. Market size and forecast, by region
    • 4.6.3. Market share analysis by country

CHAPTER 5: NASAL SPRAY MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Allergy Rhinitis
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Sinusitis
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Nasal Polyps
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospital Pharmacies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Drug Stores and Retail Pharmacies
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Online Providers
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: NASAL SPRAY MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Type
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by Distribution Channel
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Type
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by Distribution Channel
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Type
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by Distribution Channel
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Type
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by Distribution Channel
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Type
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by Distribution Channel
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Type
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by Distribution Channel
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Type
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by Distribution Channel
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Type
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by Distribution Channel
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Type
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by Distribution Channel
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Type
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by Distribution Channel
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Type
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by Distribution Channel
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Type
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by Distribution Channel
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Type
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by Distribution Channel
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Type
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by Distribution Channel
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Type
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by Distribution Channel
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Type
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by Distribution Channel
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Type
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by Distribution Channel
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Type
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by Distribution Channel
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Type
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by Distribution Channel
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Type
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by Distribution Channel
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Type
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by Distribution Channel
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Type
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by Distribution Channel
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Type
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. GlaxoSmithKline plc
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Novartis AG
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Cipla Ltd
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Bayer AG
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Viatris Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Sun Pharmaceutical Industries Ltd
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
  • 9.7. Aurena Laboratories
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
  • 9.8. Apotex Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Key strategic moves and developments
  • 9.9. Leeford Healthcare Limited
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. Sunovion Pharmaceuticals Inc.
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 02. NASAL SPRAY MARKET FOR STEROID, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. NASAL SPRAY MARKET FOR ANTIHISTAMINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. NASAL SPRAY MARKET FOR SALINE SOLUTION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. NASAL SPRAY MARKET FOR DECONGESTANT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. NASAL SPRAY MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. GLOBAL NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 08. NASAL SPRAY MARKET FOR ALLERGY RHINITIS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. NASAL SPRAY MARKET FOR SINUSITIS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. NASAL SPRAY MARKET FOR NASAL POLYPS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. NASAL SPRAY MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. GLOBAL NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 13. NASAL SPRAY MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. NASAL SPRAY MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. NASAL SPRAY MARKET FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. NASAL SPRAY MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. NORTH AMERICA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 18. NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 19. NORTH AMERICA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 20. NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. U.S. NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 22. U.S. NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 23. U.S. NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 24. CANADA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 25. CANADA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 26. CANADA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 27. MEXICO NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. MEXICO NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 29. MEXICO NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 30. EUROPE NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 31. EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 32. EUROPE NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 33. EUROPE NASAL SPRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 34. GERMANY NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. GERMANY NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. GERMANY NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 37. FRANCE NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 38. FRANCE NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 39. FRANCE NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 40. UK NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. UK NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 42. UK NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 43. ITALY NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 44. ITALY NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 45. ITALY NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 46. SPAIN NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 47. SPAIN NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 48. SPAIN NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 49. REST OF EUROPE NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 50. REST OF EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. REST OF EUROPE NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 53. ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 54. ASIA-PACIFIC NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 55. ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 56. JAPAN NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 57. JAPAN NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 58. JAPAN NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 59. CHINA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 60. CHINA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 61. CHINA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 62. INDIA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 63. INDIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 64. INDIA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 65. AUSTRALIA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 66. AUSTRALIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 67. AUSTRALIA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 68. SOUTH KOREA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. SOUTH KOREA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 70. SOUTH KOREA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 71. REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 74. LAMEA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 75. LAMEA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. LAMEA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 77. LAMEA NASAL SPRAY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 78. BRAZIL NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 79. BRAZIL NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. BRAZIL NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 81. SAUDI ARABIA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 82. SAUDI ARABIA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 83. SAUDI ARABIA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 84. SOUTH AFRICA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 85. SOUTH AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 86. SOUTH AFRICA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 87. REST OF LAMEA NASAL SPRAY MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 88. REST OF LAMEA NASAL SPRAY MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 89. REST OF LAMEA NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 90. GLAXOSMITHKLINE PLC: KEY EXECUTIVES
  • TABLE 91. GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT
  • TABLE 92. GLAXOSMITHKLINE PLC: PRODUCT SEGMENTS
  • TABLE 93. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
  • TABLE 94. NOVARTIS AG: KEY EXECUTIVES
  • TABLE 95. NOVARTIS AG: COMPANY SNAPSHOT
  • TABLE 96. NOVARTIS AG: PRODUCT SEGMENTS
  • TABLE 97. NOVARTIS AG: PRODUCT PORTFOLIO
  • TABLE 98. CIPLA LTD: KEY EXECUTIVES
  • TABLE 99. CIPLA LTD: COMPANY SNAPSHOT
  • TABLE 100. CIPLA LTD: PRODUCT SEGMENTS
  • TABLE 101. CIPLA LTD: PRODUCT PORTFOLIO
  • TABLE 102. BAYER AG: KEY EXECUTIVES
  • TABLE 103. BAYER AG: COMPANY SNAPSHOT
  • TABLE 104. BAYER AG: PRODUCT SEGMENTS
  • TABLE 105. BAYER AG: PRODUCT PORTFOLIO
  • TABLE 106. BAYER AG: KEY STRATERGIES
  • TABLE 107. VIATRIS INC.: KEY EXECUTIVES
  • TABLE 108. VIATRIS INC.: COMPANY SNAPSHOT
  • TABLE 109. VIATRIS INC.: PRODUCT SEGMENTS
  • TABLE 110. VIATRIS INC.: PRODUCT PORTFOLIO
  • TABLE 111. SUN PHARMACEUTICAL INDUSTRIES LTD: KEY EXECUTIVES
  • TABLE 112. SUN PHARMACEUTICAL INDUSTRIES LTD: COMPANY SNAPSHOT
  • TABLE 113. SUN PHARMACEUTICAL INDUSTRIES LTD: PRODUCT SEGMENTS
  • TABLE 114. SUN PHARMACEUTICAL INDUSTRIES LTD: PRODUCT PORTFOLIO
  • TABLE 115. AURENA LABORATORIES: KEY EXECUTIVES
  • TABLE 116. AURENA LABORATORIES: COMPANY SNAPSHOT
  • TABLE 117. AURENA LABORATORIES: PRODUCT SEGMENTS
  • TABLE 118. AURENA LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 119. APOTEX INC.: KEY EXECUTIVES
  • TABLE 120. APOTEX INC.: COMPANY SNAPSHOT
  • TABLE 121. APOTEX INC.: PRODUCT SEGMENTS
  • TABLE 122. APOTEX INC.: PRODUCT PORTFOLIO
  • TABLE 123. APOTEX INC.: KEY STRATERGIES
  • TABLE 124. LEEFORD HEALTHCARE LIMITED: KEY EXECUTIVES
  • TABLE 125. LEEFORD HEALTHCARE LIMITED: COMPANY SNAPSHOT
  • TABLE 126. LEEFORD HEALTHCARE LIMITED: PRODUCT SEGMENTS
  • TABLE 127. LEEFORD HEALTHCARE LIMITED: PRODUCT PORTFOLIO
  • TABLE 128. SUNOVION PHARMACEUTICALS INC.: KEY EXECUTIVES
  • TABLE 129. SUNOVION PHARMACEUTICALS INC.: COMPANY SNAPSHOT
  • TABLE 130. SUNOVION PHARMACEUTICALS INC.: PRODUCT SEGMENTS
  • TABLE 131. SUNOVION PHARMACEUTICALS INC.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. NASAL SPRAY MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF NASAL SPRAY MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN NASAL SPRAY MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. HIGH THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALNASAL SPRAY MARKET
  • FIGURE 10. NASAL SPRAY MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR STEROID, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR ANTIHISTAMINE, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR SALINE SOLUTION, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR DECONGESTANT, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 16. NASAL SPRAY MARKET, BY APPLICATION, 2021(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR ALLERGY RHINITIS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR SINUSITIS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR NASAL POLYPS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 21. NASAL SPRAY MARKET, BY DISTRIBUTION CHANNEL, 2021(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF NASAL SPRAY MARKET FOR ONLINE PROVIDERS, BY COUNTRY 2021 AND 2031(%)
  • FIGURE 25. NASAL SPRAY MARKET BY REGION, 2021
  • FIGURE 26. U.S. NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. CANADA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. MEXICO NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. GERMANY NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. FRANCE NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. UK NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. ITALY NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SPAIN NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. REST OF EUROPE NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. JAPAN NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. CHINA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. INDIA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. AUSTRALIA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH KOREA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF ASIA-PACIFIC NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. BRAZIL NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. SAUDI ARABIA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. SOUTH AFRICA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. REST OF LAMEA NASAL SPRAY MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49. COMPETITIVE DASHBOARD
  • FIGURE 50. COMPETITIVE HEATMAP: NASAL SPRAY MARKET
  • FIGURE 51. TOP PLAYER POSITIONING, 2021
  • FIGURE 52. GLAXOSMITHKLINE PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. NOVARTIS AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. NOVARTIS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. NOVARTIS AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. BAYER AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. BAYER AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 58. BAYER AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 59. VIATRIS INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. VIATRIS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. SUN PHARMACEUTICAL INDUSTRIES LTD: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 62. SUN PHARMACEUTICAL INDUSTRIES LTD: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. SUNOVION PHARMACEUTICALS INC.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 64. SUNOVION PHARMACEUTICALS INC.: REVENUE SHARE BY REGION, 2021 (%)